SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001730463-24-000064
Filing Date
2024-05-17
Accepted
2024-05-17 16:39:00
Documents
80
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q autl-20240331.htm   iXBRL 10-Q 1092544
2 EX-31.1 autolus-10xqx31032024ex311.htm EX-31.1 13903
3 EX-31.2 autolus-10xqx31032024ex312.htm EX-31.2 13856
4 EX-32.1 autolus-10xqx31032024ex321.htm EX-32.1 8840
  Complete submission text file 0001730463-24-000064.txt   6536238

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT autl-20240331.xsd EX-101.SCH 52102
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT autl-20240331_cal.xml EX-101.CAL 65638
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT autl-20240331_def.xml EX-101.DEF 251836
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT autl-20240331_lab.xml EX-101.LAB 635372
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT autl-20240331_pre.xml EX-101.PRE 446620
84 EXTRACTED XBRL INSTANCE DOCUMENT autl-20240331_htm.xml XML 847514
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38547 | Film No.: 24960511
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)